BIMI International Medical Inc. (BIMI) Financials

$0.00

south_east
-$0 (0%)
Day's range
$0
Day's range
$0

BIMI Income statement / Annual

Last year (2022), BIMI International Medical Inc.'s total revenue was $11.83 M, a decrease of 56.31% from the previous year. In 2022, BIMI International Medical Inc.'s net income was -$22.35 M. See BIMI International Medical Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Operating Revenue $11.83 M $27.08 M $12.84 M $157,978.00 $6.54 M $8.51 M $6.04 M $6.71 M $9.98 M $5.67 M
Cost of Revenue $9.88 M $22.48 M $10.40 M $304,120.00 $6.08 M $7.59 M $5.89 M $5.54 M $8.50 M $4.13 M
Gross Profit $1.95 M $4.60 M $2.44 M -$146,142.00 $459,354.00 $916,514.00 $148,769.00 $1.18 M $1.48 M $1.54 M
Gross Profit Ratio 0.16 0.17 0.19 -0.93 0.07 0.11 0.02 0.18 0.15 0.27
Research and Development Expenses $0.00 $0.00 $0.00 $0.00 $56,189.00 $73,238.00 $96,572.00 $105,168.00 $107,872.00 $79,450.00
General & Administrative Expenses $10.60 M $9.52 M $5.47 M $1.35 M $16.12 M $2.05 M $1.59 M $1.72 M $1.83 M $1.06 M
Selling & Marketing Expenses $1.30 M $3.18 M $783,134.00 $216,791.00 $133,788.00 $63,451.00 $35,820.00 $100,382.00 $32,777.00 $98,863.00
Selling, General & Administrative Expenses $11.90 M $12.70 M $6.26 M $1.57 M $16.25 M $2.11 M $1.63 M $1.82 M $1.86 M $1.16 M
Other Expenses $0.00 -$344,254.00 -$1,953.00 -$549,581.00 -$790,037.00 -$26,863.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $17.29 M $12.70 M $6.26 M $1.57 M $16.25 M $2.11 M $1.63 M $1.82 M $1.86 M $1.16 M
Cost And Expenses $27.17 M $35.19 M $16.66 M $1.87 M $22.34 M $9.70 M $7.52 M $7.36 M $10.36 M $5.29 M
Interest Income $707.00 $3,101.00 $304.00 $6,347.00 $505.00 $8.00 $14,246.00 $11,790.00 $63,153.00 $36,686.00
Interest Expense $3.43 M $351,066.00 $84,913.00 $6,340.00 $416,412.00 $353,745.00 $354,422.00 $398,641.00 $420,942.00 $592,528.00
Depreciation & Amortization $223,560.00 $244,116.00 $56,041.00 $261,983.00 $1.04 M $944,012.00 $998,189.00 $1.27 M $844,657.00 $831,084.00
EBITDA -$17.97 M -$31.98 M -$3.21 M -$1.71 M -$15.54 M -$277,914.00 -$481,860.00 $633,040.00 $468,460.00 $1.29 M
EBITDA Ratio -1.52 -0.3 -0.29 -12.66 -2.38 -0.03 -0.08 0.1 0.05 0.22
Operating Income Ratio -1.3 -0.3 -0.3 -10.84 -2.41 -0.14 -0.24 -0.1 -0.04 0.07
Total Other Income/Expenses Net -$6.28 M -$26.56 M $460,552.00 -$550,057.00 $15.58 M -$380,600.00 -$337,283.00 -$368,955.00 -$176,233.00 -$519,338.00
Income Before Tax -$21.62 M -$34.90 M -$3.35 M -$2.27 M -$17.00 M -$1.58 M -$1.82 M -$1.01 M -$552,429.00 -$133,145.00
Income Before Tax Ratio -1.83 -1.29 -0.26 -14.36 -2.6 -0.19 -0.3 -0.15 -0.06 -0.02
Income Tax Expense $6,092.00 $19,368.00 $434,306.00 $1.63 M $117.00 $2,744.00 $246.00 -$40,298.00 $64,862.00 $47,020.00
Net Income -$22.35 M -$34.92 M -$3.79 M -$3.90 M -$16.79 M -$1.57 M -$1.82 M -$969,442.00 -$617,291.00 -$180,165.00
Net Income Ratio -1.89 -1.29 -0.29 -24.66 -2.57 -0.18 -0.3 -0.14 -0.06 -0.03
EPS -8.4 -3256.11 -17.74 -23.84 -112.25 -11.1 -14 -7.74 -5.5 -1.64
EPS Diluted -8.4 -3256.11 -17.74 -23.84 -112.25 -11.1 -13.82 -7.74 -5.44 -1.64
Weighted Average Shares Out $2.66 M $10,725.00 $213,456.00 $163,383.00 $149,547.00 $141,465.00 $129,827.00 $125,306.00 $112,234.00 $109,561.00
Weighted Average Shares Out Diluted $2.66 M $10,725.00 $213,456.00 $163,383.00 $149,547.00 $141,465.00 $131,517.00 $125,306.00 $113,443.00 $109,561.00
Link